Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

Pharmaust banks $400k rebate from Feds after successful anti cancer trials

Articles In The NewsBy PharmAustJanuary 31, 2017

PharmAust receives $406K R&D rebate from ATO

News & Announcements 2017By PharmAustJanuary 30, 2017

170130_PHARMAUST RECEIVES $406K R&D REBATE FROM ATO

Appendix 4D Half-Year Report for the period ended 31 December 2016

Financial Reports 2016, Financial Reports 2017, News & Announcements 2016, News & Announcements 2017By PharmAustDecember 31, 2016

170228_Appendix 4D Half-Year Report for the period ended 31 December 2016

Appendix 4D & Half Yearly Report and Accounts

Financial Reports 2016, News & Announcements 2016By PharmAustDecember 31, 2016

160229_Appendix 4D & Half Yearly Report and Accounts

PharmAust raises a further 1.56m

News & Announcements 2016By PharmAustDecember 30, 2016

161230_PHARMAUST RAISES A FURTHER $1.56M

Completion of rights issue and notice shortfall

News & Announcements 2016By PharmAustDecember 8, 2016

161208_COMPLETION OF RIGHTS ISSUE AND NOTICE OF SHORTFALL

Rights issue – Extension of closing date

News & Announcements 2016By PharmAustDecember 5, 2016

161205_RIGHTS ISSUE – EXTENSION OF CLOSING DATE

No extension of closing date in rights issue

News & Announcements 2016By PharmAustDecember 5, 2016

161205_NO EXTENSION OF CLOSING DATE IN RIGHTS ISSUE

Argonaut Research Note

Research Notes 2016By PharmAustDecember 5, 2016

161205_Argonaut research note

Phase II Strategy Update

News & Announcements 2016By PharmAustNovember 21, 2016

161121_Phase II Strategy Update

←1
234567891011121314151617181920212223242526272829303132333435
…3637383940…
41424344454647
48→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube
TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
10h

PharmAust (ASX:PAA) completes enrolment of second patient cohort in MND/ALS trial https://themarketherald.com.au/pharmaust-asxpaa-completes-enrolment-of-second-patient-cohort-in-mnd-als-trial-2023-03-30/ via @themarketherald

Reply on Twitter 1641338317286543360 Retweet on Twitter 1641338317286543360 2 Like on Twitter 1641338317286543360 9 Twitter 1641338317286543360
pharmaust PharmAust @pharmaust ·
14h

PharmAust completes patient enrolment for MPL trial with sights on US$3.6 billion Motor Neurone Disease market

https://stockhead.com.au/health/pharmaust-completes-patient-enrolment-for-mpl-trial-with-sights-on-us3-6-billion-motor-neurone-disease-market/

Reply on Twitter 1641272193236758529 Retweet on Twitter 1641272193236758529 4 Like on Twitter 1641272193236758529 13 Twitter 1641272193236758529
pharmaust PharmAust @pharmaust ·
16h

Pandemic Pet Adoptions Propel Rise of a $500 Billion Global Market
Via ⁦@Bloomberg⁩ https://www.bloomberg.com/news/articles/2023-03-24/pet-industry-outlook-is-strong-despite-rising-costs-of-food-vet-care

Reply on Twitter 1641241590726561792 Retweet on Twitter 1641241590726561792 3 Like on Twitter 1641241590726561792 6 Twitter 1641241590726561792
Load More
Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top